Search Results

There are 13430 results for: content related to: Accurate mass filtering of ion chromatograms for metabolite identification using a unit mass resolution liquid chromatography/mass spectrometry system

  1. The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates

    Clinical Pharmacology & Therapeutics

    Volume 79, Issue 3, March 2006, Pages: 218–230, Girum L. Lemma, Zaiqi Wang, Mitchell A. Hamman, Narjis A. Zaheer, J. Christopher Gorski and Stephen D. Hall

    Version of Record online : 7 FEB 2006, DOI: 10.1016/j.clpt.2005.11.001

  2. You have free access to this content
    Effect of K+ and Rb+ on the action of verapamil on a voltage-gated K+ channel, hKv1.3: implications for a second open state?

    British Journal of Pharmacology

    Volume 157, Issue 5, July 2009, Pages: 757–768, Z Kuras and S Grissmer

    Version of Record online : 9 APR 2009, DOI: 10.1111/j.1476-5381.2009.00202.x

  3. Pharmacokinetics of P-glycoprotein inhibition in the rat blood-brain barrier

    Journal of Pharmaceutical Sciences

    Volume 97, Issue 12, December 2008, Pages: 5386–5400, Stina Syvänen, Andrew Hooker, Obaidur Rahman, Helena Wilking, Gunnar Blomquist, Bengt Långström, Mats Bergström and Margareta Hammarlund-Udenaes

    Version of Record online : 2 APR 2008, DOI: 10.1002/jps.21359

  4. Impact of concentration and rate of intraluminal drug delivery on absorption and gut wall metabolism of verapamil in humans

    Clinical Pharmacology & Therapeutics

    Volume 76, Issue 3, September 2004, Pages: 230–238, Hartmut Glaeser, Siegfried Drescher, Ute Hofmann, Georg Heinkele, Andrew A. Somogyi, Michel Eichelbaum and Martin F. Fromm

    Version of Record online : 4 SEP 2004, DOI: 10.1016/j.clpt.2004.04.013

  5. You have free access to this content
    Gut wall metabolism of verapamil in older people: effects of rifampicin-mediated enzyme induction

    British Journal of Clinical Pharmacology

    Volume 45, Issue 3, March 1998, Pages: 247–255, Martin F. Fromm, Karin Dilger, Dagmar Busse, Heyo K. Kroemer, Michel Eichelbaum and Ulrich Klotz

    Version of Record online : 4 JAN 2002, DOI: 10.1046/j.1365-2125.1998.00669.x

  6. In vivo comparison of putative probes of CYP3A4/5 activity: erythromycin, dextromethorphan, and verapamil

    Clinical Pharmacology & Therapeutics

    Volume 66, Issue 1, July 1999, Pages: 40–50, Mary Ellen Krecic-Shepard, Crissy R. Barnas, Jill Slimko, J. Christopher Gorski, Irving W. Wainer and Janice B. Schwartz

    Version of Record online : 22 JUL 1999, DOI: 10.1016/S0009-9236(99)70052-4

  7. You have free access to this content
    The effect of deep pore mutations on the action of phenylalkylamines on the Kv1.3 potassium channel

    British Journal of Pharmacology

    Volume 127, Issue 5, July 1999, Pages: 1065–1074, Heiko Rauer and Stephan Grissmer

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0702599

  8. Comprehensive cytotoxic evaluation of morin, a bioflavonoid against verapamil on rat gastrointestinal epithelium for novel pharmaceutical application involving P-glycoprotein inhibition

    Journal of Pharmacy and Pharmacology

    Volume 67, Issue 8, August 2015, Pages: 1083–1099, Gurunath Surampalli, Basavaraj K. Nanjwade and Paragouda A. Patil

    Version of Record online : 13 APR 2015, DOI: 10.1111/jphp.12400

  9. Absorption barriers in the rat intestinal mucosa: 1. application of an in situ perfusion model to simultaneously assess drug permeation and metabolism

    Journal of Pharmaceutical Sciences

    Volume 99, Issue 2, February 2010, Pages: 982–998, Daniel R. Mudra and Ronald T. Borchardt

    Version of Record online : 10 SEP 2009, DOI: 10.1002/jps.21912

  10. Extracellular calcium protects against verapamil-induced metaphase-II arrest and initiation of apoptosis in aged rat eggs

    Cell Biology International

    Volume 33, Issue 3, March 2009, Pages: 337–343, S.K. Chaube, Anima Tripathi, Sabana Khatun, S.K. Mishra, P.V. Prasad and T.G. Shrivastav

    Version of Record online : 2 JAN 2013, DOI: 10.1016/j.cellbi.2009.01.001

  11. You have free access to this content
    Oral bioavailability of dabigatran etexilate (Pradaxa®) after co-medication with verapamil in healthy subjects

    British Journal of Clinical Pharmacology

    Volume 75, Issue 4, April 2013, Pages: 1053–1062, Sebastian Härtter, Regina Sennewald, Gerhard Nehmiz and Paul Reilly

    Version of Record online : 15 MAR 2013, DOI: 10.1111/j.1365-2125.2012.04453.x

  12. Bioconcentration of two basic pharmaceuticals, verapamil and clozapine, in fish

    Environmental Toxicology and Chemistry

    Volume 35, Issue 3, March 2016, Pages: 593–603, Gopinath C. Nallani, Regina E. Edziyie, Peter M. Paulos, Barney J. Venables, Lisa A. Constantine and Duane B. Huggett

    Version of Record online : 9 FEB 2016, DOI: 10.1002/etc.3244

  13. You have free access to this content
    Involvement of the Multidrug Resistance P-Glycoprotein in Acetaminophen-Induced Toxicity in Hepatoma-Derived HepG2 and Hep3B Cells

    Basic & Clinical Pharmacology & Toxicology

    Volume 99, Issue 3, September 2006, Pages: 213–224, Irena Manov, Yulia Bashenko, Mark Hirsh and Theodore C. Iancu

    Version of Record online : 23 AUG 2006, DOI: 10.1111/j.1742-7843.2006.pto_443.x

  14. Unexpected effect of verapamil on oral bioavailability of the β-blocker talinolol in humans

    Clinical Pharmacology & Therapeutics

    Volume 65, Issue 3, March 1999, Pages: 283–290, Ute I. Schwarz, Thomas Gramatté, Jutta Krappweis, Annette Berndt, Reinhard Oertel, Oliver von Richter and Wilhelm Kirch

    Version of Record online : 10 MAR 1999, DOI: 10.1016/S0009-9236(99)70107-4

  15. Cytochrome P450 3A5 Genotype is Associated with Verapamil Response in Healthy Subjects

    Clinical Pharmacology & Therapeutics

    Volume 82, Issue 5, November 2007, Pages: 579–585, Y Jin, Y-H Wang, J Miao, L Li, R J Kovacs, R Marunde, M A Hamman, S Phillips, J Hilligoss and S D Hall

    Version of Record online : 18 APR 2007, DOI: 10.1038/sj.clpt.6100208

  16. You have free access to this content
    Pharmacologic and Therapeutic Considerations in Hypertension Therapy With Calcium Channel Blockers: Focus on Verapamil

    The Journal of Clinical Hypertension

    Volume 9, Issue 2, February 2007, Pages: 1–22, Domenic A. Sica and 1 L. Michael Prisant 2

    Version of Record online : 9 OCT 2008, DOI: 10.1111/j.1524-6175.2007.06504.x

  17. You have free access to this content
    Mechanism of verapamil block of a neuronal delayed rectifier K channel: active form of the blocker and location of its binding domain

    British Journal of Pharmacology

    Volume 126, Issue 8, April 1999, Pages: 1699–1706, L Catacuzzeno, C Trequattrini, A Petris and F Franciolini

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0702477

  18. You have free access to this content
    Verapamil for Cluster Headache. Clinical Pharmacology and Possible Mode of Action

    Headache: The Journal of Head and Face Pain

    Volume 49, Issue 1, January 2009, Pages: 117–125, Peer Tfelt-Hansen and Jacob Tfelt-Hansen

    Version of Record online : 29 OCT 2008, DOI: 10.1111/j.1526-4610.2008.01298.x

  19. Effect of Huang-Lian-Jie-Du-Decoction on pharmacokinetics of verapamil in rats

    Journal of Pharmacy and Pharmacology

    Volume 62, Issue 4, April 2010, Pages: 440–447, Shan-Shan Xie, Nan Hu, Xin-Yue Jing, Xiao-Dong Liu, Lin Xie, Guang-Ji Wang and Chang-Hui Liu

    Version of Record online : 26 MAY 2010, DOI: 10.1211/jpp.62.04.0005

  20. Imaging P-glycoprotein Transport Activity at the Human Blood-brain Barrier with Positron Emission Tomography

    Clinical Pharmacology & Therapeutics

    Volume 77, Issue 6, June 2005, Pages: 503–514, Lucy Sasongko, Jeanne M. Link, Mark Muzi, David A. Mankoff, Xiaodong Yang, Ann C. Collier, Steven C. Shoner and Jashvant D. Unadkat

    Version of Record online : 9 JUN 2005, DOI: 10.1016/j.clpt.2005.01.022